SI
CYTK icon

Sofinnova Investments’s Cytokinetics CYTK Stock Holding History

Sofinnova Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500,000
Closed -$14.7M – 67
2023
Q3 		$14.7M Buy
+500,000
New +$16.7M 0.93% 31
2020
Q4 		– Sell
-325,000
Closed -$7.04M – 71
2020
Q3 		$7.04M Buy
+325,000
New +$7.6M 0.52% 32

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sofinnova Investments's CYTK Position: Q1 2026 in Review

Sofinnova Investments opened a new position in Cytokinetics (CYTK) in Q1 2026: 91,791 shares worth $6.05M. The stake represents 0.23% of the portfolio and ranks #55 among its holdings. This is a return to the name: Sofinnova Investments previously reported a position in CYTK as recently as Q4 2023.

Sofinnova Investments first reported a position in CYTK in Q3 2019 and has held it in 17 quarters since. The position peaked at $34.6M in Q4 2023. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Sofinnova Investments held 91,791 shares of Cytokinetics worth $6.05M as of Q1 2026.
  • Cytokinetics was a new Sofinnova Investments position in Q1 2026.
  • Cytokinetics made up 0.23% of Sofinnova Investments's portfolio in Q1 2026, its #55 holding.
  • Sofinnova Investments first reported a position in Cytokinetics in Q3 2019 and has held it in 17 quarters since.
  • Sofinnova Investments's Cytokinetics position peaked at $34.6M in Q4 2023.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.